Thai FDARegulatory IntelligenceRegulation
Thai FDA GMDP / GMP Clearance

Thai Drug Facility Licensing and Good Manufacturing and Distribution Practice

Thailand licenses drug facilities by activity rather than by product, and attaches a different good-practice standard to each licence: a manufacturer owes GMDP, an importer owes GDP, and a seller owes GPP. An overseas manufacturing site supplying Thailand does not hold a Thai licence at all — it obtains GMP Clearance from the Thai FDA instead. Thailand has been the 49th PIC/S Participating Authority since 1 August 2016, so its manufacturing expectations track the PIC/S GMP Guide.

LAST REVISED
May 2023
PRODUCT AREAS
Solid DoseSterileBiotechDistribution

What this does not cover

stated in the document's own scope
  • It concerns modern drugs as described on the Thai FDA’s medicines pages; cosmetics, foods and medical devices are regulated separately.
  • GMP Clearance assesses the overseas site; it does not register the product.
  • A traveller may bring modern drugs for personal use for no longer than 30 days under section 13(4); ordering drugs into Thailand by post is not allowed.
SOURCE & PROVENANCE
ISSUING BODY
Food and Drug Administration, Thailand
JURISDICTION
Thailand
DOCUMENT ID
Thai FDA GMDP / GMP Clearance
Official site — Food and Drug Administration, Thailand ↗

Always verify against the current published text before relying on it for a submission or inspection.

Overview

Thailand regulates the manufacture, import and sale of modern drugs through licences issued under the Drugs Act B.E. 2510 (1967), administered by the Thai Food and Drug Administration. Each activity needs its own licence, and each licence carries good-practice duties. For imported finished products, the overseas manufacturing site must first be granted GMP Clearance by the Thai FDA before the importer can apply for a licence to import drug samples for registration and then for registration itself.

Scope & applicability

Drug facilities operating in or supplying Thailand: domestic manufacturing facilities, import facilities, retail and wholesale sales establishments, and overseas manufacturing sites seeking GMP Clearance. Applications are filed with the Thai FDA for facilities in Bangkok and with the Provincial Public Health Office elsewhere.

Legal basis & how it acquires force

Section 12 of the Drugs Act B.E. 2510 (1967) prohibits manufacturing, selling, importing or ordering into the kingdom any modern drug without a licence from the licensing authority. The detailed requirements for licensed activities and for GMP Clearance are set under the Act and administered by the Thai FDA. The Thai FDA has been a PIC/S participating authority since August 2016.

Document structure

PartCovers
Section 12 licencesSeparate licences to manufacture, sell, and import or order modern drugs
Domestic manufactureA licence to manufacture drug samples for registration (Form Por.Yor.8), then registration (Form Yor.1)
ImportGMP Clearance of the overseas manufacturer, a licence to import drug samples for registration (Form Nor.Yor.8), then registration (Form Yor.1)
RegistrationApplication with drug samples and technical documents on quality, efficacy and safety
Personal importModern drugs for personal use for no longer than 30 days under section 13(4)

Quick reference · Which practice standard applies to which Thai licence

Thailand attaches the good-practice obligation to the licence type, not to the product. A site that manufactures and imports holds two licences and owes both duties.

Licence heldStandard the licensee must comply with
Manufacturing facility (domestic)Good Manufacturing and Distribution Practice (GMDP)
Import facilityGood Distribution Practice (GDP)
Sales establishment (retail or wholesale)Good Pharmacy Practice (GPP)
Overseas manufacturing facilityGMP Clearance from the Thai FDA

Licences of every type are renewed yearly, and a pharmacist must be present and on duty at the establishment. Applications go to the Thai FDA in Bangkok, or to the Provincial Public Health Office elsewhere.

Source: Thai FDA, Drug Facility Licensing (en.fda.moph.go.th), 24 May 2023. Verify against the current text before relying on it for a submission.

Key requirements

  • Hold the correct licence for each activity — manufacture, import and sale are licensed separately
  • Comply with the standard attached to the licence: GMDP for manufacturers, GDP for importers, GPP for sellers
  • Obtain GMP Clearance from the Thai FDA for an overseas manufacturing site supplying the Thai market
  • Ensure a pharmacist is present and on duty at the sales establishment, manufacturing facility or import facility
  • Renew every licence annually; fee rates differ by licence type and standard

Implementation tips

  • Map your activities to licences before your products: a site that manufactures and also imports owes both GMDP and GDP
  • Treat PIC/S alignment as the working assumption for inspection expectations — Thailand acceded in 2016 and inspects against the PIC/S GMP Guide
  • For an overseas site, plan GMP Clearance as a separate, Thailand-specific submission rather than assuming an existing PIC/S-country certificate suffices
  • File in the right place: Bangkok applications go to the Thai FDA, provincial ones to the Provincial Public Health Office

Revision notes

Thailand became the 49th PIC/S Participating Authority on 1 August 2016, having applied on 20 March 2015 — the accession that aligned Thai manufacturing expectations with the PIC/S GMP Guide and made Thai certificates legible to other PIC/S authorities. Thailand is a PIC/S member alongside Singapore, Malaysia, Indonesia and Chinese Taipei, and hosts the regional inspection convergence that membership implies.

CHECKING ACCESS

Checking your access…

Where this control fails

live FDA enforcement
See all FDA enforcement →

Live FDA recalls SPEQ maps to this standard’s topics — a SPEQ interpretation, not an FDA classification.

International alignment

PIC/S is open to authorities with a GMP inspection system comparable to the other participating authorities’, and Thailand has participated since August 2016. The licensing structure attaches duties to each licensed activity — manufacture, import and sale — and requires the overseas site of an imported product to be cleared before the product can be registered.

Thai FDA GMDP / GMP Clearance: frequently asked questions

Quick answers to common questions about Thai FDA GMDP / GMP Clearance.

What are the steps to import a finished drug into Thailand?

According to the Thai FDA, the importer must be a licensed importer of modern drugs, and the steps are: GMP Clearance of the overseas manufacturer; a licence to import or order drug samples for registration (Form Nor.Yor.8); then application for registration (Form Yor.1) with samples and technical documents on quality, efficacy and safety.

When did Thailand join PIC/S?

The Thai FDA’s accession to the PIC/S Scheme took effect in August 2016, according to the PIC/S members list.

Can drugs be ordered into Thailand by post?

No. The Thai FDA states that because section 12 of the Drugs Act requires a licence to import or order modern drugs, bringing drugs in or ordering them to be shipped by post is not allowed.